cyclosporine has been researched along with Myelodysplastic Syndromes in 178 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 31 (17.42) | 18.2507 |
| 2000's | 94 (52.81) | 29.6817 |
| 2010's | 46 (25.84) | 24.3611 |
| 2020's | 7 (3.93) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Du, Y; Han, B; Ruan, J; Yang, C | 1 |
| Al Ali, NH; Epling-Burnette, PK; Haider, M; Komrokji, RS; Lancet, JE; List, AF; Padron, E; Zhang, Q | 1 |
| Dou, A; Fang, J; Feng, S; Halene, S; Hawkins, C; He, X; Lawley, L; Mizukawa, B; Patel, A; Roman-Rivera, A; Wunderlich, M; Zhang, J | 1 |
| Arber, D; Avigan, DE; Foss, FM; Gascoyne, RD; Hogan, WJ; Horning, SJ; Jegede, O; Lazarus, HM; Litzow, MR; Luger, SM; Miller, KB; Sprague, KA; Stadtmauer, EA; Strair, RK; Tallman, MS; Wagner, H; Wang, XV; Whiteside, TL | 1 |
| Buizen, L; Butler, JP; Chang, K; Cooney, J; Curley, C; Durrant, S; Gartlan, KH; Gottlieb, D; Henden, AS; Hill, GR; Kennedy, GA; Misra, A; Moore, J; Morton, AJ; Olver, SD; Paul, SK; Ritchie, D; Subramoniapillai, E; Tey, SK; Varelias, A | 1 |
| Fu, R; Niu, H; Shao, Z; Wang, H; Xing, L; Zhang, T | 1 |
| Abgueguen, P; Cottin, L; Daniel, V; Dieu, X; François, S; Giltat, A; Hunault, M; Lacombe, V; Nunes Gomes, C; Orvain, C; Riou, J; Robin, JB; Schmidt, A; Thépot, S; Ugo, V | 1 |
| Balleari, E; Bernal, T; Beyne-Rauzy, O; Bordessoule, D; Calabuig, M; Cametti, G; Campelo, MD; Cheze, S; Cony-Makhoul, P; Dreyfus, F; Fenaux, P; Fensterl, J; Ferrero, D; Gaidano, G; Germing, U; Gioia, D; Götze, K; Guerci-Bresler, A; Hamel, JF; Kaivers, J; Kelaidi, C; Komrokji, R; Kotsianidis, I; Müller-Thomas, C; Pane, F; Park, S; Ramos, F; Roboz, GJ; Rose, C; Sanna, A; Santini, V; Sanz, GF; Sapena, R; Sekeres, MA; Stamatoullas, A; Steensma, DP; Thépot, S; Toma, A; Vey, N; Wattel, E | 1 |
| Alyea, EP; Bashey, A; Deeg, HJ; Devine, SM; Fernandez, HF; Geller, NL; Giralt, S; Hamadani, M; Horowitz, MM; Horwitz, ME; Le-Rademacher, J; Leifer, E; Logan, BR; Maziarz, RT; Mendizabal, AM; Pasquini, MC; Porter, DL; Scott, BL; Warlick, ED; Wu, J | 1 |
| Koba, Y; Tamekane, A; Watanabe, M | 1 |
| Nohgawa, M; Oka, S; Ono, K | 1 |
| Cai, JF; Chen, Y; Guan, JL; Hua, YQ; Ma, HF; Shen, Y; Zou, J | 1 |
| Iglesias-González, M; Monge, MF; Robles-Martínez, M | 1 |
| Almeida, A | 1 |
| Ades, L; Arana, R; Baran-Marszak, F; Braun, T; Cereja, S; Eclache, V; Fenaux, P; Gardin, C; Kelaidi, C; Lazarian, G; Letestu, R; Lusina, D; Marceau-Renaut, A; Martin, A; Preudhomme, C; Soret, J | 1 |
| Cevreska, L; Chadievski, L; Georgievski, B; Stavridis, IP; Stojanoski, Z; Trajkova, S; Veljanovska, AP | 1 |
| Chen, XJ; Hama, A; Ito, M; Kojima, S; Yang, WY; Zhang, PH; Zhu, XF | 1 |
| Baba, M; Hata, T; Imaizumi, Y; Imanishi, D; Miyazaki, Y; Nagai, K; Taguchi, J; Tomonaga, M; Tsushima, H | 1 |
| Hiramoto, N; Iwasa, T; Matsuura, T; Ohashi, K; Shoji, M | 1 |
| Tohyama, K | 1 |
| Hu, J; Wang, Q; Wang, Y; Wei, X; Zhan, X | 1 |
| Amagai, M; Fujio, Y; Funakoshi, T; Kakuta, R; Ohyama, M; Yasuda, F | 1 |
| Arihiro, K; Asaoku, H; Ichinohe, T; Mihara, K; Mino, T; Yoshida, T | 1 |
| Chen, X; Hama, A; Hasegawa, D; Hirabayashi, S; Ishida, Y; Ito, M; Kojima, S; Manabe, A; Masunaga, A; Nakahata, T; Tsuchida, M; Watanabe, S; Yoshimi, A; Zaike, Y | 1 |
| Imokawa, S; Kageyama, H; Nishimoto, K; Sagisaka, S; Sato, J; Suda, T; Suzuki, S; Uto, T; Yasuda, K | 1 |
| Bao, JA; Ding, XL; Miao, LY; Xue, L; Zhang, JJ; Zhang, WW | 1 |
| Furukawa, S; Hayashi, K; Hirose, T; Kohguchi, K; Matsuhashi, Y; Sugihara, T; Tasaka, T; Tohyama, K; Wada, H | 1 |
| Gao, YT; Qian, LL; Shen, JP; Wen, XW; Ye, BD; Zhang, Y; Zhou, YH | 1 |
| Mittelman, M; Oster, HS | 1 |
| Ge, M; Huang, J; Huang, Z; Li, X; Nie, N; Shao, Y; Shi, J; Wang, M; Zhang, J; Zheng, Y | 1 |
| Hama, A; Ito, E; Ito, M; Kobayashi, R; Kojima, S; Kosaka, Y; Muramatsu, H; Narita, A; Ohara, A; Ohga, S; Takahashi, Y; Tsuchida, M; Yabe, H | 1 |
| Cheng, Y; Wu, J; Zhang, L | 1 |
| Fang, L; Hu, N; Li, B; Pan, L; Qin, T; Qu, S; Wang, J; Xiao, Z; Xu, Z; Zhang, H; Zhang, Y | 1 |
| Chen, YH; Ding, Y; Liang, AB; Luo, X; Wu, H | 1 |
| Means, RT | 1 |
| Baek, JH; Kim, H; Kim, MY; Lee, EH; Min, YJ; Noh, EK; Park, JH; Shin, SJ | 1 |
| Auteri, A; Di Renzo, M; Gotti, G; Pasqui, AL; Pompella, G; Voltolini, L | 1 |
| Akaogi, T; Kawata, E; Kiyota, M; Kobayashi, Y; Kuroda, J; Sasaki, N; Taniwaki, M | 1 |
| Chen, J; Tang, Y; Young, NS | 1 |
| Beran, M; Borthakur, G; Brandt, M; Cortes, J; Faderl, S; Garcia-Manero, G; Garg, R; Huang, X; Kantarjian, H; Koller, C; Pierce, S; Ravandi, F; York, S | 1 |
| Sloand, EM | 1 |
| Peng, CT; Yang, YS; Yao, CY; Yeh, SP | 1 |
| Kojima, S | 1 |
| Katayama, Y; Kawamori, Y; Kawano, H; Kawano, Y; Matsui, T; Minagawa, K; Nishikawa, S; Okamura, A; Ono, K; Shimoyama, M; Yamamori, M | 1 |
| Cho, HJ; Heo, S; Jeon, IS | 1 |
| Barrett, AJ; Sloand, EM | 2 |
| Du, X; Gu, X; Hao, F; Li, C; Li, H; Ma, J; Song, Y; Zhang, S; Zhang, Z | 1 |
| Fang, L; Qin, T; Xiao, Z; Xu, Z; Zhang, H; Zhang, Y | 1 |
| Tsuda, H; Tsuji, T; Yamasaki, H | 1 |
| Elad, S; Gesundheit, B; Levovic, A; Miron, S; Or, R; Resnick, IB; Shapira, MY; Slavin, S; Tsirigotis, PD; Yoffe, L; Zilberman, I | 1 |
| Domracheva, EV; Dvirnyk, VN; Kaplanskaia, IB; Kokhno, AV; Mikhaĭlova, EA; Ol'shanskaia, IuV; Parovichnikova, EN; Savchenko, VG; Ustinova, EN | 1 |
| Hao, YS; Liu, KQ; Qin, TJ; Xiao, ZJ; Xu, ZF; Zhang, Y | 1 |
| Aul, C; Dobbelstein, C; Ganser, A; Giagounidis, AA; Hofmann, WK; Ossenkoppele, G; Passweg, JR; Schilling, K; Simcock, M; Stadler, M; Tichelli, A | 1 |
| Hirayama, M; Iyama, S; Kato, J; Kobune, M; Kuroiwa, G; Murase, K; Okamoto, T; Sagawa, T; Sato, T; Sato, Y; Takada, K; Takahashi, S; Takimoto, R; Tanaka, S | 1 |
| Cevreska, L; Jovanovic, R; Pavkovic, M; Petrusevska, G; Stojanovic, A | 1 |
| Beutel, G; Buchholz, S; Dammann, E; Eder, M; Ganser, A; Krauter, J; Stadler, M; Trummer, A | 1 |
| Arihiro, K; Fujii, M; Harada, H; Harada, Y; Kimura, A; Nitta, H; Okikawa, Y | 1 |
| Li, X; Lingyun, W; Luxi, S; Qi, Z; Qiusheng, C; Xiao, L | 1 |
| Bertz, H; Engelhardt, M; Finke, J; Grüllich, C; Ihorst, G; Marks, R; Spyridonidis, A; Wäsch, R | 1 |
| Lin, G; Wang, W; Wang, X; Xu, X | 1 |
| Borthakur, G; Brandt, M; Estrov, Z; Faderl, S; Garcia-Manero, G; Huang, X; Jabbour, E; Kadia, TM; Kantarjian, HM; Koller, C; Pierce, S; Ravandi, F; York, S | 1 |
| Arnan, M; Bermúdez, A; Caballero, T; Duarte, RF; Montes, C; Patiño, B; Sánchez-Ortega, I; Vázquez, L; Yáñez, L | 1 |
| Barrett, AJ; Olnes, MJ; Parikh, AR | 1 |
| Barrett, AJ; Loberiza, F; Maciejewski, JP; Molldrem, J; Nakamura, R; Nam, JM; Robyn, J; Saunthararajah, Y; Simonis, T; Young, NS | 1 |
| Atoyebi, W; Brunskill, S; Bywater, L; Littlewood, TJ; Rawlings, L | 1 |
| Frickhofen, N; Heimpel, H; Kaltwasser, JP; Schrezenmeier, H | 1 |
| Andretta, C; Catalano, L; Luciano, L; Maciejewski, JP; Ricci, P; Rotoli, B; Selleri, C | 1 |
| Kakishita, E; Okada, M; Okamoto, T; Takatsuka, H; Wakae, T | 1 |
| Fujii, S; Kikuchi, T; Miyata, A; Yasuda, Y | 1 |
| Apsit, TK; Berlina, NV; Ermolin, VV; Klimiuk, SI; Rukavitsyn, OA; Shcherbakov, NM | 1 |
| Chen, PM; Fuh, JL; Hsiao, LT; Lin, JT; Lirng, JF; Wang, SJ | 1 |
| Aoki, K; Chiba, S; Goyama, S; Hirai, H; Kanda, Y; Kandabashi, K; Kawazu, M; Komeno, Y; Kurokawa, M; Motokura, T; Nakamoto, T; Nannya, Y; Niino, M; Ogawa, S; Takeshita, M; Tsujino, S | 1 |
| Asano, T; Cai, LZ; Hayakawa, J; Maeda, M; Migita, M; Orimoto, M; Ueda, T | 1 |
| Ohyashiki, K; Shimamoto, T | 2 |
| Blacklock, H; Charman, R; Jackson, S; Kalluru, R; Nisbet, M; Royle, G | 1 |
| Fujimori, Y; Hara, H; Kakishita, E; Mori, A; Okada, M; Okamoto, T; Takatsuka, H; Wakae, T | 1 |
| Chen, XY; Deng, CS; Ma, R | 1 |
| Asano, Y; Mizoguchi, H; Mori, H; Niho, Y; Ohyashiki, K; Okamoto, T; Omine, M; Shimamoto, T; Teramura, M; Tohyama, K; Tomonaga, M; Uchiyama, T | 1 |
| Barrett, AJ; Nakamura, R; Saunthararajah, Y; Wang, QJ; Wesley, R | 1 |
| Hara, T; Kasahara, S; Moriwaki, H; Sawada, M; Tsurumi, H; Yamada, T | 1 |
| Fujino, Y; Hisasue, M; Masuda, K; Ohno, K; Tezuka, K; Tsujimoto, H | 1 |
| Hasselbalch, HC; Larsen, MS | 1 |
| Estey, EH; Giles, FJ; Kantarjian, HM; Kurzrock, R; O'Brien, SA; Tsimberidou, AM; Yazji, S | 1 |
| Eom, HS; Han, CW; Jeong, DC; Lee, JH; Lee, SH; Lim, JH; Park, SJ | 1 |
| Arlet, P; Astudillo, L; Dahan, S; Delisle, MB; Ecoiffier, M; Joseph-Hein, K; Madaule, S; Sailler, L | 1 |
| Akiyama, H; Hiruma, K; Mikoshiba, M; Ohashi, K; Okuyama, Y; Sakamaki, H; Tanaka, Y | 1 |
| Guan, M | 1 |
| Bartynski, WS; Lister, J; Shadduck, RK; Zeigler, ZR | 1 |
| Cantisani, V; Glickman, J; Mortele, KJ; Ros, PR; Silverman, SG; Viscomi, SG | 1 |
| Chuhjo, T | 1 |
| Kishida, S; Ohta, K; Sakamaki, H; Yoritaka, A | 1 |
| Ikewaki, J; Imamura, T; Kikuchi, H; Kohno, K; Nakayama, T; Nasu, M; Ogata, M; Ogata, Y; Ohtsuka, E; Ono, K; Saburi, Y | 1 |
| Choi, SJ; Kim, S; Kim, WK; Lee, JH; Lee, JS; Lee, KH; Lee, YS; Seol, M | 1 |
| Dobrea, C; Gioadă, L; Gologan, R; Ostroveanu, D | 1 |
| Fujisaki, G; Inokuchi, C; Kami, M; Kishi, Y; Momomura, S; Murashige, N; Tanosaki, R | 1 |
| Chen, P; Liu, B; Liu, XD; Lou, JX; Ning, F; Wang, JW | 1 |
| Chatterjee, T; Choudhary, DR; Choudhry, VP; Dixit, A; Mahapatra, M; Mishra, P; Saxena, R | 1 |
| Fenk, R; Germing, U; Graef, T; Haas, R; Hinke, A; Kobbe, G; Neumann, F; Steidl, U; Tapprich, C; Vaupel, M | 1 |
| Auerbach, AD; Defor, TE; Macmillan, ML; Slungaard, A; Tan, PL; Wagner, JE | 1 |
| Chen, YR; Gong, M; Huang, FZ; Li, ZL; Ma, YG; Xu, SH | 1 |
| Hellström-Lindberg, E | 1 |
| Hara, T; Kanemura, N; Moriwaki, H; Tsurumi, H; Yamada, T | 1 |
| Arber, C; Buser, A; Gratwohl, A; Heim, D; Passweg, JR; Tichelli, A | 1 |
| Kato, Y; Kohno, A; Morishita, Y; Narimatsu, H; Saito, S; Shimada, K | 1 |
| Deeg, HJ; Ishikawa, T; List, A; Marsh, J; Nakao, S; Tomonaga, M | 1 |
| Barrett, J; Sloand, E; Young, N | 1 |
| Nunez, O; Scheinberg, P; Wu, C; Young, NS | 1 |
| Fujimaki, K; Hyo, R; Kanda, Y; Kurakawa, M; Maruta, A; Mori, T; Okamoto, S; Onoda, M; Oshima, K; Sakai, M; Sakamaki, H; Sakura, T; Taguchi, J; Tanaka, M; Yamashita, T | 1 |
| Akiyama, H; Kamata, N; Kisida, S; Ohashi, K; Ohta, K; Sakai, M; Sakamaki, H; Yamashita, T | 1 |
| Bacigalupo, A; Bekassy, A; Fuehrer, M; Locasciulli, A; Marsh, J; Mary, JY; Passweg, J; Schrezenmeier, H; Socie, G; Tichelli, A | 1 |
| Hu, NP; Liu, L; Shu, X | 1 |
| Chen, SC; Da, WM; Gong, M; Guan, M; Jiang, B | 1 |
| Doyle, J; Somech, R | 1 |
| Hayashi, N; Hino, M; Kanashima, H; Koh, H; Koh, KR; Mochizuki, K; Nakamae, H; Nakamae, M; Nakane, T; Sakamoto, E; Takeoka, Y; Yamane, T | 1 |
| Chen, S; Da, W; Gong, M; Guan, M; Jiang, B | 1 |
| Baumann, I; Bergsträsser, E; Fischer, A; Führer, M; Göbel, U; Gross-Wieltsch, U; Klingebiel, T; Niemeyer, C; Nöllke, P; Sykora, KW; van den Heuvel-Eibrink, MM; Yoshimi, A | 1 |
| Hara, M; Hino, M; Hori, A; Kami, M; Kanda, Y; Kim, SW; Mineishi, S; Mori, S; Ohashi, Y; Saito, AM; Suzuki, R; Takami, A; Takaue, Y; Takemoto, Y; Taniguchi, S; Yamaguchi, M; Yoshida, T | 1 |
| Bessho, M; Dan, K; Fujishima, N; Hirokawa, M; Nakao, S; Omine, M; Ozawa, K; Sawada, K; Teramura, M; Tsurumi, H; Urabe, A | 1 |
| Ishikawa, T; Kurokawa, M; Mitani, K; Motoji, T; Nakao, S; Omine, M; Takatoku, M; Teramura, M; Tohyama, K; Uchiyama, T; Yoshida, Y | 1 |
| Bakhshi, S; Goel, R; Kumar, R | 1 |
| Rezvani, K; Sloand, EM | 1 |
| Chen, H; Chen, Y; Chen, YH; Han, W; Huang, XJ; Liu, DH; Liu, KY; Lu, DP; Shi, HX; Wang, JZ; Wang, Y; Xu, LP; Zhang, XU; Zhang, YC | 1 |
| Chae, H; Cho, SG; Han, K; Kim, M; Kim, Y; Lee, JW; Lim, J | 1 |
| Mitani, K | 1 |
| Barrett, J; Greenberg, P; Sloand, EM; Wu, CO; Young, N | 1 |
| Ayuk, F; Bacher, U; Binder, T; Diyachenko, G; Eiermann, T; Erttmann, R; Fehse, B; Kabisch, H; Kröger, N; Panse, J; Wolschke, C; Zabelina, T; Zander, AR | 1 |
| Caballero, D; Calvo, MV; de la Cámara, R; de Oteiza, JP; Heras, I; Martino, R; Pérez-Simón, JA; Rebollo, N; San Miguel, JF; Sierra, J; Valcarcel, D | 1 |
| Baxter-Lowe, LA; Bunin, N; Camitta, B; Casper, J; Garbrecht, F; Hunter, J; Lawton, C; Murray, K; Pietryga, D; Truitt, R | 1 |
| Attal, M; Brousset, P; Dastugue, N; Demur, C; Duchayne, E; Rigal-Huguet, F; Robert, A; Rubie, H | 1 |
| Abella, E; de Planque, MM; Eisenbrey, AB; Karanes, C; Lum, LG; Ratanatharathorn, V; Ravindranath, Y; Schultz, KR; Sensenbrenner, LL; Uberti, JP | 1 |
| Favre, H; Lemoine, R; Miescher, PA | 1 |
| Epstein, JB; Reece, DE | 1 |
| Akashi, K; Eto, T; Gondo, H; Harada, M; Hayashi, S; Nagafuji, K; Takamatsu, Y; Taniguchi, S; Teshima, T; Yamasaki, K | 1 |
| Belanger, R; Boileau, J; Bonny, Y; Kassis, J; Lacombe, M; Lalonde, Y; Lavallee, R; Perreault, C; Roy, DC; von Bueltzingsloewen, A | 1 |
| Ezaki, K; Hirano, M; Kojima, H; Maruyama, F; Tsuzuki, M | 1 |
| Anasetti, C; Anderson, JE; Appelbaum, FR; Bensinger, WI; Bryant, E; Buckner, CD; Chauncey, T; Clift, RA; Gooley, T; Schoch, G | 1 |
| Okumura, H; Takamatsu, H; Yoshida, T | 1 |
| Clarke, P; Fleming, CJ; Kemmett, D | 1 |
| Biesma, DH; van den Tweel, JG; Verdonck, LF | 1 |
| Acebedo, G; Alvarez-Sabín, J; Grivé, E; Rovira-Cañellas, A | 1 |
| Anasetti, C; Appelbaum, FR; Boeckh, M; Chauncey, TR; Deeg, HJ; Doney, K; Flowers, M; Leisenring, W; Lin, D; Martin, P; Nash, R; Schoch, G; Storb, R; Sullivan, KM; Witherspoon, RP | 1 |
| Bertz, H; Finke, J; Mertelsmann, R; Potthoff, K | 1 |
| Akatsuka, J; Hamajima, N; Imashuku, S; Kigasawa, H; Kiriyama, Y; Kojima, S; Ohara, A; Ohta, S; Okamura, J; Sasaki, H; Sugita, K; Tsuchida, M; Tsukimoto, I | 1 |
| Ezaki, K; Hirano, M; Ino, T; Okamoto, M; Tsuzuki, M; Yamaguchi, T | 1 |
| Lewerin, C; Mobacken, H; Nilsson-Ehle, H; Swolin, B | 1 |
| Deguchi, S; Kikuchi, T; Miyata, A; Osada, T; Sanada, H | 1 |
| Hosoya, T; Kaito, K; Katayama, T; Kobayashi, M; Masuoka, H; Nishiwaki, K; Ogasawara, Y; Otsubo, H; Sekita, T; Shimada, T | 1 |
| Arrighini, A; Facchetti, F; Laffranchi, MG; Porta, F; Tettoni, K; Ugazio, AG | 1 |
| Antunes, NL; Boulad, F; George, D; Lis, E; Small, TN | 1 |
| Bangerter, M; Griesshammer, M; Hafner, M; Heil, G; Heiss, M; Kern, P; Kern, W; Krauter, J; v Tirpitz, C | 1 |
| Lärfars, G; Samuelsson, J | 1 |
| Elgie, AW; Lewandowicz, GM; Sargent, JM; Taylor, CG; Williamson, CJ | 1 |
| Hibi, S; Kadono, Y; Tabata, Y; Takanashi, M | 1 |
| Berer, A; Geissler, K; Lechner, K; Ohler, L; Simonitsch, I; Thalhammer, R | 1 |
| Fujimora, Y; Kakishita, E; Okada, M; Okamoto, T; Takatsuka, H; Takemoto, Y; Tamura, A; Wada, H; Yamada, S | 1 |
| Dolan, G; Gould, J; Myers, B | 1 |
| Albrechtsen, D; Brinch, L; Egeland, T; Evensen, SA; Heldal, D; Solheim, BG; Steen, R; Tjønnfjord, G | 1 |
| Katagiri, T; Kuriya, S; Ohyashiki, K; Sashida, G; Tauchi, T | 1 |
| Chao, NJ; Morgenlander, JC; Shbarou, RM | 1 |
| Asaka, M; Hashino, S; Imamura, M; Kobayashi, S; Mori, A; Ota, S; Tanaka, J; Yamamoto, Y | 1 |
| Baron, F; Beguin, Y; Fillet, G; Gothot, A; Hermanne, JP; Pierard, GE; Salmon, JP | 1 |
| Arcese, W; Bacigalupo, A; Di Bona, E; Locasciulli, A; Locatelli, F | 1 |
| Durrant, S; Irving, I; Mollee, P; Morton, AJ | 1 |
| Ando, K; Hayashi, S; Kimura, Y; Miyazawa, K; Mukai, K; Ohyashiki, K; Serizawa, H; Shimamoto, T; Yguchi, M | 1 |
| Imamura, A; Kato, Y; Mihara, M; Miwa, H; Miyashita, M; Nitta, M; Sugamura, K; Tajima, E; Wakabayashi, M; Watarai, M | 1 |
| Ando, K; Iguchi, T; Ito, Y; Katagiri, T; Kimura, Y; Masuda, M; Miyazawa, K; Mizoguchi, H; Ohyashiki, K; Shimamoto, T; Tauchi, T; Yaguchi, M | 1 |
| Bittencourt, MA; Bonfim, CM; Brandi, IV; Camargo, CH; de Medeiros, CR; Friedrich, ML; Pasquini, R; Teive, HA; Werneck, LC | 1 |
| Itoh, M; Shimada, H; Tohyama, K; Yago, K | 1 |
| Ishikawa, T; Tohyama, K | 1 |
| Okamoto, T | 1 |
| Baron, F; Baudoux, E; Beguin, Y; Fillet, G; Matus, G; Sautois, B | 1 |
| Imamura, S; Kuwata, A; Shirasaki, H; Tsutani, H; Ueda, T; Yamashita, T; Yamauchi, T | 1 |
| Bessell, EM; Hunter, AE; Russell, NH | 1 |
| Calhoun, L; Champlin, RE; Gajewski, JL; Ho, WG; Hunt, LA; Landaw, EM; Lyddane, NR; O'Rourke, S; Petz, LD; Schiller, GJ | 1 |
| Andersson, BS; Brunner, LJ; Deisseroth, AB; Dimopoulos, MA; Huan, SD; Spencer, V; Spitzer, G; Wallerstein, RO; Woo, SY; Yau, JC | 1 |
| Ashby, M; Atkinson, K; Biggs, J; Concannon, A; Dodds, A; Downs, K; Wilson, F; Young, S | 1 |
15 review(s) available for cyclosporine and Myelodysplastic Syndromes
| Article | Year |
|---|---|
[Myelodysplastic syndromes: treatment strategy up-to-date].
Topics: Antilymphocyte Serum; Azacitidine; Benzoates; Cyclosporine; Cytarabine; Deferasirox; Disease Progression; Drug Discovery; Drug Therapy, Combination; Erythropoietin; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Immunosuppressive Agents; Iron Chelating Agents; Lenalidomide; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Quality of Life; Risk Assessment; Thalidomide; Triazoles | 2014 |
[Case of organizing pneumonia associated with sweet's syndrome].
Topics: Aged; Cryptogenic Organizing Pneumonia; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Myelodysplastic Syndromes; Neutrophils; Prednisolone; Pulse Therapy, Drug; Skin; Sweet Syndrome; Tacrolimus; Treatment Outcome | 2014 |
Pure red cell aplasia.
Topics: Adrenal Cortex Hormones; Anemia, Diamond-Blackfan; Autoimmune Diseases; Cyclosporine; Humans; Immunosuppressive Agents; Leukemia, Large Granular Lymphocytic; Leukemia, Lymphocytic, Chronic, B-Cell; Myelodysplastic Syndromes; Parvoviridae Infections; Parvovirus B19, Human; Thymoma; Vasculitis | 2016 |
Hypocellular myelodysplasia.
Topics: Age Factors; Animals; Antilymphocyte Serum; Bone Marrow Cells; Cyclosporine; Humans; Immunosuppressive Agents; Myelodysplastic Syndromes; Prognosis | 2009 |
Iron chelation therapy for patients with myelodysplastic syndrome.
Topics: Antilymphocyte Serum; Chelation Therapy; Cyclosporine; Ferritins; Hematopoietic Stem Cell Transplantation; Humans; Iron; Iron Chelating Agents; Iron Overload; Myelodysplastic Syndromes; Thalassemia | 2009 |
[Recent progress in the diagnosis and treatment of aplastic anemia in children].
Topics: Anemia, Aplastic; Animals; Antilymphocyte Serum; Bone Marrow Transplantation; Child; Combined Modality Therapy; Cyclosporine; Diagnosis, Differential; Drug Therapy, Combination; Granulocyte Colony-Stimulating Factor; Histocompatibility; HLA Antigens; Humans; Immunosuppression Therapy; Myelodysplastic Syndromes; Rabbits; Sirolimus | 2009 |
Immunosuppression for myelodysplastic syndrome: how bench to bedside to bench research led to success.
Topics: Adult; Aged; Aged, 80 and over; Antilymphocyte Serum; Apoptosis; Biomedical Research; Bone Marrow; Clinical Medicine; Clinical Trials as Topic; Cyclosporine; Cytokines; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Male; Middle Aged; Myelodysplastic Syndromes; T-Lymphocytes; Tumor Necrosis Factor-alpha | 2010 |
[Successful treatment with cyclosporine for myelodysplastic syndrome with erythroid hypoplasia following rheumatoid arthritis].
Topics: Arthritis, Rheumatoid; Cyclosporine; Erythroid Cells; Female; Humans; Immunosuppressive Agents; Myelodysplastic Syndromes; Treatment Outcome | 2010 |
Immunomodulatory treatment of myelodysplastic syndromes: antithymocyte globulin, cyclosporine, and alemtuzumab.
Topics: Alemtuzumab; Antibodies, Monoclonal, Humanized; Antilymphocyte Serum; Antineoplastic Agents; Cyclosporine; Humans; Immunologic Factors; Immunosuppressive Agents; Myelodysplastic Syndromes; Treatment Outcome | 2012 |
Immunosuppressive treatments for myelodysplastic syndromes.
Topics: Autoimmune Diseases; Blotting, Southern; CD4 Antigens; CD8 Antigens; Cell Lineage; Clinical Trials as Topic; Cyclosporine; Gene Rearrangement; Genes, T-Cell Receptor alpha; Humans; Immunosuppressive Agents; Karyotyping; Models, Biological; Myelodysplastic Syndromes; Pilot Projects; Receptors, Antigen, T-Cell, gamma-delta | 2003 |
[Application of cyclosporine A in myelodysplastic syndrome--review].
Topics: Cyclosporine; Humans; Immunosuppressive Agents; Myelodysplastic Syndromes | 2003 |
Response to cyclosporine therapy in patients with myelodysplastic syndrome: a clinical study of 12 cases and literature review.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Myelodysplastic Syndromes; Treatment Outcome | 2004 |
The role of the immune system in myelodysplasia: implications for therapy.
Topics: Antilymphocyte Serum; Cyclosporine; Humans; Immune System; Immunosuppressive Agents; Myelodysplastic Syndromes; T-Lymphocytes; Tumor Necrosis Factor-alpha; Vaccines | 2008 |
[Myelodysplastic syndrome].
Topics: alpha Catenin; Antineoplastic Agents; Azacitidine; Cholecalciferol; Cyclosporine; Decitabine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Lenalidomide; Myelodysplastic Syndromes; Prognosis; Thalidomide; Vitamin K 2; World Health Organization | 2008 |
Relapsing polychondritis and myelodysplasia: a report of two cases and review of the current literature.
Topics: Aged; Aged, 80 and over; Anemia, Refractory; Anemia, Sideroblastic; Blood Transfusion; Bone Marrow; Cyclosporine; Fatal Outcome; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Polychondritis, Relapsing; Prednisolone; Thrombocytopenia | 2000 |
34 trial(s) available for cyclosporine and Myelodysplastic Syndromes
| Article | Year |
|---|---|
SF3B1 Mutations Negatively Predict for Response to Immunosuppressive Therapy in Myelodysplastic Syndromes.
Topics: Adult; Aged; Aged, 80 and over; Antilymphocyte Serum; Cyclosporine; Female; HLA-DR Serological Subtypes; Humans; Immunosuppressive Agents; Male; Middle Aged; Mutation; Myelodysplastic Syndromes; Phosphoproteins; Predictive Value of Tests; RNA Splicing Factors | 2020 |
Incorporation of extracorporeal photopheresis into a reduced intensity conditioning regimen in myelodysplastic syndrome and aggressive lymphoma: results from ECOG 1402 and 1902.
Topics: Adult; Allografts; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Pentostatin; Photopheresis; Tacrolimus; Transplantation Conditioning; Whole-Body Irradiation | 2020 |
A phase 3 double-blind study of the addition of tocilizumab vs placebo to cyclosporin/methotrexate GVHD prophylaxis.
Topics: Adult; Antibodies, Monoclonal, Humanized; Cyclosporine; Double-Blind Method; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Placebo Effect; Transplantation, Homologous; Treatment Outcome | 2021 |
Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cause of Death; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Melphalan; Middle Aged; Myelodysplastic Syndromes; Recurrence; Survival Rate; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation; Young Adult | 2017 |
Comparison of long-term outcomes between children with aplastic anemia and refractory cytopenia of childhood who received immunosuppressive therapy with antithymocyte globulin and cyclosporine.
Topics: Anemia, Aplastic; Antilymphocyte Serum; Child; Child, Preschool; Chromosome Deletion; Chromosome Disorders; Chromosomes, Human, Pair 7; Cyclosporine; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Infant; Leukemia, Myeloid, Acute; Male; Myelodysplastic Syndromes; Prospective Studies | 2015 |
A pilot dose-escalating study of alemtuzumab plus cyclosporine for patients with bone marrow failure syndrome.
Topics: Adolescent; Adult; Aged; Alemtuzumab; Anemia, Aplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Bone Marrow Diseases; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Pilot Projects; Red-Cell Aplasia, Pure; Survival Rate; Treatment Outcome; Young Adult | 2009 |
Phase II study of rabbit anti-thymocyte globulin, cyclosporine and granulocyte colony-stimulating factor in patients with aplastic anemia and myelodysplastic syndrome.
Topics: Adult; Aged; Aged, 80 and over; Anemia, Aplastic; Animals; Antilymphocyte Serum; Cyclosporine; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Myelodysplastic Syndromes; Rabbits | 2009 |
[Efficiency of cyclosporin A therapy in patients with myelodysplastic syndrome].
Topics: Adolescent; Adult; Aged; Bone Marrow; Chromosome Aberrations; Cyclosporine; Dose-Response Relationship, Drug; Female; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Karyotyping; Male; Middle Aged; Myelodysplastic Syndromes; Prognosis; Young Adult | 2010 |
Immunosuppressive therapy for patients with myelodysplastic syndrome: a prospective randomized multicenter phase III trial comparing antithymocyte globulin plus cyclosporine with best supportive care--SAKK 33/99.
Topics: Adult; Aged; Antilymphocyte Serum; Cell Transformation, Neoplastic; Cross-Over Studies; Cyclosporine; Drug Therapy, Combination; Female; Health Services; Humans; Immunosuppressive Agents; Intention to Treat Analysis; Logistic Models; Male; Middle Aged; Myelodysplastic Syndromes; Prospective Studies; Survival Analysis | 2011 |
Cytoreductive treatment with clofarabine/ara-C combined with reduced-intensity conditioning and allogeneic stem cell transplantation in patients with high-risk, relapsed, or refractory acute myeloid leukemia and advanced myelodysplastic syndrome.
Topics: Adenine Nucleotides; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Clofarabine; Cyclosporine; Cytarabine; Disease-Free Survival; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycophenolic Acid; Myelodysplastic Syndromes; Retrospective Studies; Stem Cell Transplantation; Survival Rate; Transplantation Conditioning; Transplantation, Homologous | 2012 |
Final results of the phase II study of rabbit anti-thymocyte globulin, ciclosporin, methylprednisone, and granulocyte colony-stimulating factor in patients with aplastic anaemia and myelodysplastic syndrome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia, Aplastic; Antilymphocyte Serum; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Female; Glucocorticoids; Granulocyte Colony-Stimulating Factor; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Survival Analysis; Treatment Outcome; Young Adult | 2012 |
Treatment of myelodysplasia with oral cyclosporin.
Topics: Administration, Oral; Aged; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Myelodysplastic Syndromes; Phenotype; Quality of Life; Treatment Failure | 2002 |
Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia.
Topics: Anemia, Aplastic; Antilymphocyte Serum; Blood Cell Count; Cyclosporine; Disease-Free Survival; Drug Therapy, Combination; Follow-Up Studies; Hemoglobinuria, Paroxysmal; Humans; Immunosuppressive Agents; Kinetics; Leukemia; Methylprednisolone; Myelodysplastic Syndromes; Neoplasms; Recurrence; Remission Induction; Salvage Therapy; Survival Rate | 2003 |
Cyclosporin A therapy for patients with myelodysplastic syndrome: multicenter pilot studies in Japan.
Topics: Adolescent; Adult; Aged; Anemia, Refractory; Anemia, Refractory, with Excess of Blasts; Blood Platelets; Bone Marrow; Cell Lineage; Cyclosporine; Drug Evaluation; Erythrocytes; Female; Humans; Immunosuppressive Agents; Japan; Karyotyping; Male; Middle Aged; Myelodysplastic Syndromes; Neutrophils; Pilot Projects; Treatment Outcome | 2003 |
Antithymocyte globulin (ATG)-based therapy in patients with myelodysplastic syndromes.
Topics: Adult; Aged; Antilymphocyte Serum; Blood Transfusion; Cyclosporine; Female; Hematocrit; Humans; Immunosuppressive Agents; Karyotyping; Male; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Platelet Count; Treatment Outcome | 2003 |
Cyclosporine alone vs cyclosporine plus methotrexate for post-transplant immunosuppression after HLA-identical sibling bone marrow transplantation: a randomized prospective study.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; HLA Antigens; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Prospective Studies; Recurrence; Siblings; Survival Rate; Tissue Donors | 2004 |
Cyclosporin A in myelodysplastic syndrome: a preliminary report.
Topics: Adult; Aged; Anemia, Refractory; Anemia, Refractory, with Excess of Blasts; Anemia, Sideroblastic; Bone Marrow; Cyclosporine; Female; Humans; Leukocyte Count; Male; Middle Aged; Myelodysplastic Syndromes; Platelet Count; Renal Insufficiency; Treatment Outcome | 2005 |
Treatment of severe aplastic anaemia with combined immunosuppression: anti-thymocyte globulin, ciclosporin and mycophenolate mofetil.
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Antilymphocyte Serum; Child; Child, Preschool; Combined Modality Therapy; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Myelodysplastic Syndromes; Recurrence; Survival Analysis; Treatment Outcome | 2006 |
[Effect of TCM syndrome-typing based therapy combined with cyclosporin in treating myelodysplastic syndrome].
Topics: Adult; Aged; Cyclosporine; Drugs, Chinese Herbal; Female; Humans; Immunosuppressive Agents; Male; Medicine, Chinese Traditional; Middle Aged; Myelodysplastic Syndromes; Phytotherapy; Treatment Outcome | 2006 |
Treatment of myelodysplastic syndrome with cyclosporin A.
Topics: Adolescent; Adult; Aged; Anemia, Refractory; Anemia, Refractory, with Excess of Blasts; Anemia, Sideroblastic; Bone Marrow; Child; Cyclosporine; Female; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Remission Induction; Survival Rate; Treatment Outcome | 2007 |
Prospective phase II trial to evaluate the complications and kinetics of chimerism induction following allogeneic hematopoietic stem cell transplantation with fludarabine and busulfan.
Topics: Adult; Aged; Busulfan; Cyclosporine; Drug Therapy, Combination; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lymphocyte Count; Lymphocyte Transfusion; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Postoperative Complications; Prospective Studies; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2007 |
A prospective study of cyclosporine A treatment of patients with low-risk myelodysplastic syndrome: presence of CD55(-)CD59(-) blood cells predicts platelet response.
Topics: Adolescent; Adult; Aged; Blood Platelets; CD55 Antigens; CD59 Antigens; Cyclosporine; Erythrocyte Count; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Myelodysplastic Syndromes; Neutrophils; Platelet Count; Predictive Value of Tests; Prognosis; Prospective Studies; Risk Assessment; Treatment Outcome | 2007 |
Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors.
Topics: Adolescent; Adult; Antilymphocyte Serum; Child; Child, Preschool; Cyclosporine; Disease-Free Survival; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Infant; Leukemia; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Survival Rate; Transplantation Conditioning | 2008 |
Reduced-intensity conditioning allogeneic transplantation from unrelated donors: evaluation of mycophenolate mofetil plus cyclosporin A as graft-versus-host disease prophylaxis.
Topics: Adolescent; Adult; Antineoplastic Agents; Bone Marrow Transplantation; Busulfan; Combined Modality Therapy; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Male; Melphalan; Middle Aged; Mycophenolic Acid; Myeloablative Agonists; Myelodysplastic Syndromes; Peripheral Blood Stem Cell Transplantation; Survival Analysis; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2008 |
Intensified conditioning regimen with busulfan followed by allogeneic BMT in children with myelodysplastic syndromes.
Topics: Anemia, Refractory; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Combined Modality Therapy; Cyclosporine; Cytarabine; Drug Therapy, Combination; Female; Humans; Male; Melphalan; Methotrexate; Myelodysplastic Syndromes; Transplantation, Homologous; Whole-Body Irradiation | 1994 |
Use of cyclosporine in the treatment of autoimmune disorders.
Topics: Adult; Arthritis, Rheumatoid; Autoimmune Diseases; Cyclosporine; Female; Humans; Kidney; Lupus Erythematosus, Systemic; Male; Methotrexate; Myelodysplastic Syndromes; Recurrence | 1994 |
Topical cyclosporin A for treatment of oral chronic graft-versus-host disease.
Topics: Administration, Topical; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Humans; Leukemia; Male; Middle Aged; Mouth Diseases; Mouthwashes; Myelodysplastic Syndromes | 1994 |
Cyclosporine combined with methylprednisolone or methotrexate in prophylaxis of moderate to severe acute graft-versus-host disease.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Incidence; Japan; Leukemia, Myeloid; Male; Methotrexate; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Severity of Illness Index | 1993 |
Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide, and total-body irradiation and analysis of prognostic factors.
Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Graft vs Host Disease; Humans; Immunosuppression Therapy; Infections; Karyotyping; Methotrexate; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Prognosis; Recurrence; Regression Analysis; Survival Rate; Treatment Outcome; Whole-Body Irradiation | 1996 |
Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: a prospective, randomized trial.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cause of Death; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Incidence; Infant; Infections; Male; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Prospective Studies; Recurrence; Respiratory Insufficiency; Transplantation Conditioning; Treatment Outcome | 1997 |
A randomised study of allogeneic transplantation with stem cells from blood or bone marrow.
Topics: Adolescent; Adult; Bone Marrow Cells; Cyclosporine; Family; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Leukocyte Count; Living Donors; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Platelet Count; Primary Myelofibrosis; Survival Analysis; Transplantation, Homologous | 2000 |
Treatment of aplastic anaemia with granulocyte-colony stimulating factor and risk of malignancy. Italian Aplastic Anaemia Study Group.
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Antilymphocyte Serum; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Hemoglobinuria, Paroxysmal; Humans; Immunosuppressive Agents; Infant; Leukemia; Male; Middle Aged; Mouth Neoplasms; Myelodysplastic Syndromes; Neoplasms; Risk Factors; Survival Analysis; Treatment Outcome | 2001 |
Optimization of recombinant human erythropoietin therapy after allogeneic hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Child; Cyclosporine; Drug Administration Schedule; Erythropoietin; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myelodysplastic Syndromes; Recombinant Proteins; Thrombocytosis; Transplantation, Homologous | 2002 |
A prospective randomised trial of cyclosporin and methotrexate versus cyclosporin, methotrexate and prednisolone for prevention of graft-versus-host disease after HLA-identical sibling marrow transplantation for haematological malignancy.
Topics: Actuarial Analysis; Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Family; Female; Graft vs Host Disease; HLA Antigens; Humans; Incidence; Leukemia; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Neoplasm Recurrence, Local; Prednisolone; Prospective Studies; Survival Analysis; Treatment Outcome | 1991 |
129 other study(ies) available for cyclosporine and Myelodysplastic Syndromes
| Article | Year |
|---|---|
Plasma lipidome acts as diagnostic marker and predictor for cyclosporin response in patients with aplastic anemia.
Topics: Anemia, Aplastic; Arachidonic Acid; Cyclosporine; Humans; Hydroxyeicosatetraenoic Acids; Leukotriene B4; Lipidomics; Myelodysplastic Syndromes | 2023 |
Cyclosporine enhances the sensitivity to lenalidomide in MDS/AML in vitro.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cyclosporine; DNA-Binding Proteins; Drug Resistance, Neoplasm; Gene Expression Regulation, Leukemic; Humans; Ikaros Transcription Factor; Lenalidomide; Leukemia, Myeloid, Acute; Mice; Mice, Inbred NOD; Muscle Proteins; Myelodysplastic Syndromes; Neoplasm Proteins; Up-Regulation; Xenograft Model Antitumor Assays | 2020 |
Low- and intermediate-risk myelodysplastic syndrome with pure red cell aplasia.
Topics: Aged; Androgens; Cyclosporine; Erythropoietin; Female; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Male; Middle Aged; Myelodysplastic Syndromes; Prognosis; Red-Cell Aplasia, Pure; Retrospective Studies; Sirolimus | 2021 |
Risk of infection according to the gamma globulin level in the 100 days following allogeneic stem cell transplantations.
Topics: Aged; Bacterial Infections; Cyclosporine; Female; gamma-Globulins; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins, Intravenous; Immunologic Deficiency Syndromes; Immunosuppressive Agents; Leukemia; Lymphoma; Male; Middle Aged; Mycophenolic Acid; Mycoses; Myeloablative Agonists; Myelodysplastic Syndromes; Opportunistic Infections; Prognosis; ROC Curve; Transplantation Conditioning; Transplantation, Homologous; Virus Activation | 2021 |
Outcome of Lower-Risk Patients With Myelodysplastic Syndromes Without 5q Deletion After Failure of Erythropoiesis-Stimulating Agents.
Topics: Aged; Aged, 80 and over; Anemia; Antilymphocyte Serum; Antineoplastic Agents; Arsenic; Azacitidine; Chromosome Deletion; Chromosomes, Human, Pair 5; Cyclosporine; Cytarabine; Decitabine; Disease Progression; Enzyme Inhibitors; Erythrocyte Transfusion; Female; Hematinics; Humans; Hydroxyurea; Immunologic Factors; Lenalidomide; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Recurrence; Retreatment; Retrospective Studies; Risk Factors; Survival Rate; Thalidomide; Treatment Failure; Tretinoin; Valproic Acid | 2017 |
Successful treatment of calcineurin inhibitor-induced pain syndrome with acute graft versus host disease by switching calcineurin inhibitors followed by pregabalin.
Topics: Aged; Calcineurin Inhibitors; Combined Modality Therapy; Cyclosporine; Drug Monitoring; Drug Therapy, Combination; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hip; Humans; Lower Extremity; Male; Myelodysplastic Syndromes; Pain; Pregabalin; Severity of Illness Index; Tacrolimus; Transplantation, Homologous; Treatment Outcome | 2017 |
Successful Treatment of Syndrome of Inappropriate Antidiuretic Hormone Secretion Associated with Neuro-Sweet Disease in Myelodysplastic Syndrome.
Topics: Aged; Anti-Inflammatory Agents; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Inappropriate ADH Syndrome; Myelodysplastic Syndromes; Prednisolone; Sweet Syndrome | 2018 |
Infliximab associated with life-threatening lung infection in a patient with Behcet disease with intestinal and hematopoietic system involvement: A case report.
Topics: Antirheumatic Agents; Behcet Syndrome; Cyclosporine; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Pneumonia; Thalidomide | 2017 |
Cyclosporine-Olanzapine Drug-Drug Interaction.
Topics: Adult; Anemia, Aplastic; Antipsychotic Agents; Cyclosporine; Drug Interactions; Humans; Immunosuppressive Agents; Male; Myelodysplastic Syndromes; Olanzapine; Schizophrenia, Paranoid; Young Adult | 2018 |
Should more MDS patients be treated with immune-suppression?
Topics: Antilymphocyte Serum; Cyclosporine; DNA Mutational Analysis; Humans; Immunosuppression Therapy; Myelodysplastic Syndromes | 2018 |
Outcomes and mutational analysis of patients with lower-risk non-del5q myelodysplastic syndrome treated with antithymocyte globulin with or without ciclosporine A.
Topics: Aged; Antilymphocyte Serum; Cyclosporine; Disease Progression; DNA Mutational Analysis; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Myelodysplastic Syndromes; Retrospective Studies; Treatment Outcome | 2018 |
Posterior Reversible Encephalopathy Syndrome (PRES) in Children Undergoing Allogeneic Stem Cell Transplantation.
Topics: Child; Cyclosporine; Fatal Outcome; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Myelodysplastic Syndromes; Neurotoxicity Syndromes; Posterior Leukoencephalopathy Syndrome; Stem Cell Transplantation; Transplantation, Homologous | 2019 |
[Clinical features of cytopenia with bone marrow hypoplasia in children: an analysis of 100 cases].
Topics: Adolescent; Anemia, Aplastic; Bone Marrow; Child; Child, Preschool; Cyclosporine; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Myelodysplastic Syndromes; Pancytopenia | 2013 |
Long-term outcome of immunosuppressive therapy for Japanese patients with lower-risk myelodysplastic syndromes.
Topics: Adult; Aged; Aged, 80 and over; Antilymphocyte Serum; Cause of Death; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Japan; Male; Middle Aged; Myelodysplastic Syndromes; Retrospective Studies; Time Factors; Treatment Outcome | 2013 |
[Complete remission of repeated recurrent membranous nephropathy after non-myeloablative allogeneic peripheral blood stem cell transplantation].
Topics: Allografts; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Male; Middle Aged; Myelodysplastic Syndromes; Peripheral Blood Stem Cell Transplantation; Recurrence; Remission Induction; Treatment Outcome | 2013 |
[Efficacy analysis of cyclosporine in treatment of trisomy 8 myelodysplastic syndrome].
Topics: Adult; Aged; Chromosomes, Human, Pair 8; Cyclosporine; Female; Humans; Karyotyping; Male; Middle Aged; Myelodysplastic Syndromes; Retrospective Studies; Trisomy; Young Adult | 2014 |
Use of cyclosporin A for successful management of steroid-resistant Sweet's syndrome patient with possible myelodysplastic syndrome.
Topics: Adrenal Cortex Hormones; Aged; Cyclosporine; Drug Resistance; Humans; Immunosuppressive Agents; Male; Myelodysplastic Syndromes; Sweet Syndrome | 2014 |
Concurrent administration of darbepoetin alfa, cyclosporine A, and prednisolone is useful for T cell large granular lymphocyte leukemia associated with myelodysplastic syndrome complicated by Coombs-negative hemolytic anemia.
Topics: Aged; Anemia, Hemolytic; Coombs Test; Cyclosporine; Darbepoetin alfa; Drug Therapy, Combination; Erythropoietin; Humans; Leukemia, Large Granular Lymphocytic; Male; Myelodysplastic Syndromes; Prednisolone | 2014 |
Clinical characteristics and treatment outcome in 65 cases with refractory cytopenia of childhood defined according to the WHO 2008 classification.
Topics: Adolescent; Antilymphocyte Serum; Child; Child, Preschool; Cyclosporine; Disease Progression; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Male; Myelodysplastic Syndromes; Pancytopenia; Prospective Studies; Treatment Outcome; World Health Organization | 2014 |
Population pharmacokinetics and individualized dosage prediction of cyclosporine in allogeneic hematopoietic stem cell transplant patients.
Topics: Adult; Anemia, Aplastic; ATP Binding Cassette Transporter, Subfamily B; Cohort Studies; Cyclosporine; Cytochrome P-450 CYP3A; Female; Graft Rejection; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Models, Biological; Myelodysplastic Syndromes; Polymorphism, Genetic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation, Homologous | 2014 |
Delayed false elevation of circulating tacrolimus concentrations after cord blood transplantation in a patient with myelodysplastic syndrome.
Topics: Behcet Syndrome; Cord Blood Stem Cell Transplantation; Cyclosporine; False Positive Reactions; Graft vs Host Disease; Humans; Immunoassay; Immunosuppressive Agents; Male; Middle Aged; Myelodysplastic Syndromes; Tacrolimus | 2014 |
[Treatment of myelodysplastic syndrome by hematopoietic stem cell transplantation combined with Chinese medical syndrome typing: a clinical study].
Topics: Biomedical Research; Blood Platelets; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Drugs, Chinese Herbal; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Medicine, Chinese Traditional; Methotrexate; Myelodysplastic Syndromes; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2015 |
Immunosuppressive Therapy in Myelodysplastic Syndromes Is Still Alive.
Topics: Adjuvants, Immunologic; Cyclosporine; Female; Humans; Levamisole; Male; Myelodysplastic Syndromes | 2015 |
Cyclosporine Combined with Levamisole for Lower-Risk Myelodysplastic Syndromes.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Child; Cyclosporine; Disease Progression; Female; Humans; Levamisole; Male; Middle Aged; Myelodysplastic Syndromes; Retrospective Studies; Survival Analysis; Young Adult | 2015 |
Comparison of immune manifestations between refractory cytopenia of childhood and aplastic anemia in children: A single-center retrospective study.
Topics: Adolescent; Agammaglobulinemia; Anemia, Aplastic; Antilymphocyte Serum; Autoantibodies; Autoimmune Diseases; Bone Marrow; Child; Child, Preschool; Comorbidity; Complement C3; Complement C4; Cyclosporine; Female; Gene Rearrangement, delta-Chain T-Cell Antigen Receptor; Humans; Hypergammaglobulinemia; Immunoglobulins; Immunosuppressive Agents; Incidence; Infant; Lymphocyte Count; Lymphocyte Subsets; Male; Myelodysplastic Syndromes; Retrospective Studies; Time Factors | 2015 |
[Long- term outcome of thalidomide and cyclosporine in patients with IPSS low/intermediate- 1 myelodysplastic syndromes].
Topics: Adaptor Proteins, Signal Transducing; Anemia; Blood Platelets; Blood Transfusion; Bone Marrow; China; Cyclosporine; Erythrocytes; Humans; Myelodysplastic Syndromes; Neutrophils; Peptide Hydrolases; Remission Induction; Retrospective Studies; Thalidomide; Treatment Outcome; Ubiquitin-Protein Ligases | 2015 |
[Clinical Efficacy Comparison of Ultralow Dose of Decitabine and Cyclosporine on Low-risk and Intermediate-risk Type 1 of Myelodysplastic Syndrome].
Topics: Azacitidine; Cyclosporine; Decitabine; Humans; Myelodysplastic Syndromes; Pancytopenia; Retrospective Studies; Survival Rate; Treatment Outcome | 2016 |
Myelodysplasia and Good syndrome. A case report.
Topics: Aged; Cyclosporine; Humans; Immunologic Deficiency Syndromes; Male; Myelodysplastic Syndromes | 2008 |
Thrombotic thrombocytopenic purpura associated with myelodysplastic syndrome.
Topics: Adult; Anti-Inflammatory Agents; Blood Cell Count; Bone Marrow; Cyclosporine; Female; Humans; Immunosuppressive Agents; Myelodysplastic Syndromes; Plasma Exchange; Prednisolone; Pregnancy; Pregnancy Complications, Hematologic; Purpura, Thrombotic Thrombocytopenic | 2008 |
Expansion of haematopoietic stem cells from normal donors and bone marrow failure patients by recombinant hoxb4.
Topics: Anemia, Aplastic; Animals; Antigens, CD34; Bone Marrow Cells; Cells, Cultured; Cyclosporine; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Therapy, Combination; Hematopoietic Stem Cells; Homeodomain Proteins; Humans; Immunosuppressive Agents; Mice; Mice, SCID; Myelodysplastic Syndromes; Recombinant Proteins; Transcription Factors | 2009 |
Extended mycophenolate mofetil administration beyond day 30 in allogeneic hematopoietic stem cell transplantation as preemptive therapy for severe graft-versus-host disease.
Topics: Adult; Aged; Cyclosporine; Drug Administration Schedule; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Male; Middle Aged; Mycophenolic Acid; Myelodysplastic Syndromes; Safety; Tacrolimus; Time Factors; Transplantation, Homologous; Young Adult | 2009 |
A case of posterior reversible encephalopathy syndrome in a child with myelodysplastic syndrome following allogenic bone marrow transplantation.
Topics: Adolescent; Brain; Brain Edema; Cyclosporine; Diffusion Magnetic Resonance Imaging; Epilepsy, Tonic-Clonic; Female; Headache; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Myeloablative Agonists; Myelodysplastic Syndromes; Posterior Leukoencephalopathy Syndrome; Postoperative Complications; Transplantation Conditioning; Transplantation, Homologous; Water-Electrolyte Imbalance | 2010 |
Immunosuppressive therapy of cyclosporin A for severe benzene-induced haematopoietic disorders and a 6-month follow-up.
Topics: Adolescent; Adult; Anemia, Aplastic; Benzene; Bone Marrow Diseases; Cyclosporine; Female; Follow-Up Studies; Hematologic Tests; Humans; Immunosuppressive Agents; Myelodysplastic Syndromes; Occupational Exposure; Testosterone; Young Adult | 2010 |
Immunosuppressive therapy for myelodysplastic syndromes: refining the indications.
Topics: Antilymphocyte Serum; Clinical Trials as Topic; Cyclosporine; Humans; Immunization; Immunosuppression Therapy; Immunosuppressive Agents; Myelodysplastic Syndromes; Stem Cell Transplantation; Treatment Outcome; Tumor Necrosis Factor-alpha | 2008 |
Cyclosporin A and thalidomide in patients with myelodysplastic syndromes: Results of a pilot study.
Topics: Adult; Aged; Cyclosporine; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Pilot Projects; Thalidomide; Treatment Outcome | 2011 |
Post-hematopoietic stem cell transplantion immune-mediated cytopenias.
Topics: Adult; Aged; Bone Marrow; Chimerism; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Histocompatibility; Humans; Immunoglobulins, Intravenous; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myelodysplastic Syndromes; Neutropenia; Postoperative Complications; Red-Cell Aplasia, Pure; Remission Induction; Thrombocytopenia; Transplantation Conditioning | 2009 |
[Cyclosporine A in combination with thalidomide for the treatment of patients with myelodysplastic syndromes].
Topics: Anemia, Refractory, with Excess of Blasts; Cyclosporine; Humans; Myelodysplastic Syndromes; Thalidomide; Treatment Outcome | 2010 |
A case of ulcerative colitis accompanied with myelodysplastic syndrome successfully treated by cyclosporine.
Topics: Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents; Male; Middle Aged; Myelodysplastic Syndromes | 2011 |
Immunosupressive treatment with cyclosporin-A for a patient with hypoplastic myelodisplastic syndrome: a case report.
Topics: Blood Transfusion; Bone Marrow; Cyclosporine; Drug Monitoring; Female; Humans; Immunosuppressive Agents; Middle Aged; Myelodysplastic Syndromes; Pancytopenia; Treatment Outcome | 2011 |
Good's syndrome-associated pure red cell aplasia with myelodysplastic syndrome.
Topics: Aged; Bone Marrow; Combined Modality Therapy; Comorbidity; Cyclosporine; Humans; Immunologic Deficiency Syndromes; Immunosuppressive Agents; Male; Myelodysplastic Syndromes; Radiotherapy; Red-Cell Aplasia, Pure; T-Lymphocytes; Thymectomy; Thymoma; Thymus Neoplasms | 2011 |
The use of selective immunosuppressive therapy on myelodysplastic syndromes in targeted populations results in good response rates and avoids treatment-related disease progression.
Topics: Adolescent; Adult; Aged; Alemtuzumab; Antibodies, Monoclonal, Humanized; Antilymphocyte Serum; Bone Marrow Cells; Cell Transformation, Neoplastic; Child; Cyclosporine; Disease Progression; Female; Humans; Immunosuppressive Agents; Karyotype; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; T-Lymphocytes; Treatment Outcome; Young Adult | 2012 |
Marrow versus blood-derived stem cell grafts for allogeneic transplantation from unrelated donors in patients with active myeloid leukemia or myelodysplasia.
Topics: Adolescent; Adult; Antilymphocyte Serum; Antineoplastic Agents; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Female; Follow-Up Studies; Germany; Humans; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Peripheral Blood Stem Cell Transplantation; Prospective Studies; Secondary Prevention; Severity of Illness Index; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Unrelated Donors | 2012 |
Diagnosis and treatment of acquired aplastic anaemia in adults: 142 cases from a multicentre, prospective cohort study in Shanghai, China.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Androgens; Anemia, Aplastic; Antilymphocyte Serum; Bone Marrow; China; Cyclosporine; Diagnosis, Differential; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Lymphocyte Count; Male; Middle Aged; Multivariate Analysis; Myelodysplastic Syndromes; Prognosis; Prospective Studies; Reticulocyte Count; Treatment Outcome; Young Adult | 2011 |
Effect of posaconazole on cyclosporine blood levels and dose adjustment in allogeneic blood and marrow transplant recipients.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Blood Transfusion; Bone Marrow Transplantation; Cyclosporine; Drug Interactions; Drug Monitoring; Female; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Lymphoproliferative Disorders; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Triazoles; Young Adult | 2012 |
HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome.
Topics: Adult; Anemia, Aplastic; Antilymphocyte Serum; Cohort Studies; Cyclosporine; HLA-DR Antigens; HLA-DR Serological Subtypes; HLA-DR2 Antigen; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Middle Aged; Myelodysplastic Syndromes; Prognosis | 2002 |
Effects of cyclosporine on hematopoietic and immune functions in patients with hypoplastic myelodysplasia: in vitro and in vivo studies.
Topics: Adult; Aged; Anemia, Refractory; Antibodies, Monoclonal; Antigens, CD34; Antigens, Surface; CD4 Antigens; Cells, Cultured; Cyclosporine; Fas Ligand Protein; fas Receptor; Female; Flow Cytometry; Hematopoiesis; Hematopoietic Stem Cells; Humans; Immunosuppressive Agents; Interferon-gamma; Ligands; Male; Membrane Glycoproteins; Middle Aged; Myelodysplastic Syndromes; T-Lymphocyte Subsets; T-Lymphocytes | 2002 |
Effect of eicosapentaenoic acid in patients with refractory myelodysplastic syndrome.
Topics: Aged; Arachidonic Acids; Blood Transfusion; Bone Marrow; Cyclosporine; Hemostatics; Humans; Male; Myelodysplastic Syndromes; Platelet Count; Treatment Outcome; Vitamin K 2 | 2002 |
[Outcome of immunosuppressive therapy for myelodysplastic syndromes: results of 12 cases from a single institution].
Topics: Adult; Aged; Antilymphocyte Serum; Cyclosporine; Female; Humans; Immunosuppressive Agents; Lymphocytes; Male; Middle Aged; Myelodysplastic Syndromes; Treatment Outcome | 2002 |
[Experience in treating patients with myelodysplastic syndromes with cyclosporin A].
Topics: Aged; Cyclosporine; Humans; Myelodysplastic Syndromes | 2002 |
Prolonged reversible vasospasm in cyclosporin A-induced encephalopathy.
Topics: Adult; Anemia, Hemolytic, Autoimmune; Brain Edema; Brain Ischemia; Cerebral Cortex; Cyclosporine; Diffusion Magnetic Resonance Imaging; Female; Humans; Magnetic Resonance Angiography; Middle Cerebral Artery; Myelodysplastic Syndromes; Neurologic Examination; Posterior Cerebral Artery; Vasospasm, Intracranial | 2003 |
Reduced-intensity bone marrow transplantation from an alternative unrelated donor for myelodysplastic syndrome of first-donor origin.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Myelodysplastic Syndromes; Recurrence; Remission Induction; Tissue Donors; Transplantation Chimera; Transplantation Conditioning | 2003 |
Successful immunosuppressive therapy for a child with Myelodysplastic syndrome.
Topics: Anemia, Refractory; Anti-Inflammatory Agents; Antilymphocyte Serum; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Methylprednisolone; Myelodysplastic Syndromes | 2003 |
Myelodysplastic syndrome with erythroid hypoplasia is a new clinical entity responsive to cyclosporin A therapy.
Topics: Bone Marrow Cells; Cyclosporine; Erythrocytes; Gene Rearrangement; Hematologic Diseases; Humans; Immunosuppressive Agents; Myelodysplastic Syndromes; Stem Cells; T-Lymphocytes; Time Factors | 2002 |
Cyclosporin successfully treats red cell aplasia associated with myelodysplasia.
Topics: Aged; Anemia, Macrocytic; Bone Marrow Examination; Cyclosporine; Humans; Male; Myelodysplastic Syndromes; Red-Cell Aplasia, Pure; Thrombocytopenia | 2003 |
Prognostic value of cyclic GMP in patients undergoing allogeneic bone marrow transplantation after conditioning with total body irradiation.
Topics: Adolescent; Adult; Biomarkers; Blast Crisis; Bone Marrow Transplantation; Cyclic GMP; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Methylprednisolone; Monitoring, Physiologic; Myelodysplastic Syndromes; Neoplasm Staging; Nitric Oxide; Prognosis; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation | 2003 |
[Study on treatment of myelo-dysplastic syndrome by intergrative traditional Chinese and Western medicine].
Topics: Aged; Cyclosporine; Drugs, Chinese Herbal; Female; Humans; Male; Myelodysplastic Syndromes; Phytotherapy | 2003 |
A simple method to predict response to immunosuppressive therapy in patients with myelodysplastic syndrome.
Topics: Adult; Aged; Antilymphocyte Serum; Cohort Studies; Cyclosporine; HLA-DR Antigens; HLA-DR Serological Subtypes; Humans; Immunosuppressive Agents; Logistic Models; Middle Aged; Myelodysplastic Syndromes; Treatment Outcome | 2003 |
Immunosuppressive therapy for myelodysplastic syndrome: efficacy of methylprednisolone pulse therapy with or without cyclosporin A.
Topics: Aged; Aged, 80 and over; Cyclosporine; Drug Therapy, Combination; Female; Hemoglobins; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Pulse Therapy, Drug; Survival Analysis; Treatment Outcome | 2003 |
Clinicopathological features and therapy of myelodysplastic syndromes in two dogs.
Topics: Administration, Oral; Animals; Cyclosporine; Death, Sudden; Dog Diseases; Dogs; Male; Myelodysplastic Syndromes; Prednisolone | 2003 |
[Immunosuppressive treatment of the myelodysplastic syndrome].
Topics: Anemia, Refractory; Antilymphocyte Serum; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Multicenter Studies as Topic; Myelodysplastic Syndromes; Paraproteinemias | 2003 |
Cyclosporine A in the treatment of a patient with immune thrombocytopenia accompanied by myelodysplastic syndrome and nephrotic syndrome.
Topics: Aged; Cyclosporine; Female; Humans; Immunosuppressive Agents; Myelodysplastic Syndromes; Nephrotic Syndrome; Purpura, Thrombocytopenic, Idiopathic; Remission Induction | 2003 |
Pustular vasculitis in a patient with T-cell large granular lymphocyte proliferation and myelodysplasia. Successful treatment by ciclosporin.
Topics: Aged; Cyclosporine; Humans; Immunosuppressive Agents; Lymphocytosis; Male; Myelodysplastic Syndromes; Vasculitis, Leukocytoclastic, Cutaneous | 2003 |
[Sustained remission of MDS overt leukemia associated with abrupt discontinuation of immunosuppression following relapse after the second course of allogeneic hematopoietic stem cell transplantation].
Topics: Adult; Cyclosporine; Female; Humans; Leukemia; Myelodysplastic Syndromes; Peripheral Blood Stem Cell Transplantation | 2003 |
Pretransplantation conditioning influence on the occurrence of cyclosporine or FK-506 neurotoxicity in allogeneic bone marrow transplantation.
Topics: Adolescent; Adult; Aged; Bone Marrow Transplantation; Cerebral Cortex; Cyclosporine; Female; Humans; Immunosuppressive Agents; Leukemia; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Myelodysplastic Syndromes; Neurotoxicity Syndromes; Retrospective Studies; Survival Rate; Tacrolimus; Tomography, X-Ray Computed; Transplantation Conditioning; Whole-Body Irradiation | 2004 |
Rectal inflammation as first manifestation of graft-vs-host disease: radiologic-pathologic findings.
Topics: Adult; Biopsy, Needle; Bone Marrow Transplantation; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Immunohistochemistry; Myelodysplastic Syndromes; Prednisolone; Proctitis; Rectum; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome | 2003 |
[Immunosuppressive therapy for low-risk MDS: markers for good response].
Topics: Anemia, Refractory; Cyclosporine; Granulocytes; Hemoglobinuria, Paroxysmal; Humans; Immunosuppressive Agents; Myelodysplastic Syndromes | 2004 |
[Immunosuppressive-associated encephalopathy in bone marrow transplant recipients].
Topics: Acute Disease; Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Brain Diseases; Cyclosporine; Female; Humans; Immunosuppressive Agents; Leukemia; Male; Middle Aged; Myelodysplastic Syndromes; Tacrolimus | 2004 |
Hypoplastic myelodysplastic syndrome transformed in acute myeloid leukemia after androgens and cyclosporin. A treatment.
Topics: Acute Disease; Adult; Antineoplastic Agents, Alkylating; Cyclosporine; Female; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Melphalan; Myelodysplastic Syndromes; Treatment Failure | 2003 |
Sinus bradycardia associated with cyclosporine following allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Bradycardia; Cyclosporine; Hematopoietic Stem Cell Transplantation; Humans; Male; Myelodysplastic Syndromes; Transplantation, Homologous | 2005 |
[A preliminary report on treatment of myelodysplastic syndrome with cyclosporin a and androgen].
Topics: Adolescent; Adult; Aged; Androgens; Blood Cell Count; Cyclosporine; Drug Therapy, Combination; Female; Hemoglobins; Humans; Immunosuppressive Agents; Male; Middle Aged; Myelodysplastic Syndromes; Treatment Outcome | 2004 |
Cyclosporine A and mycophenolate mofetil vs cyclosporine A and methotrexate for graft-versus-host disease prophylaxis after stem cell transplantation from HLA-identical siblings.
Topics: Adolescent; Adult; Cyclosporine; Female; Graft vs Host Disease; Histocompatibility; Histocompatibility Testing; HLA Antigens; Humans; Immunosuppressive Agents; Leukemia; Living Donors; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Myelodysplastic Syndromes; Recurrence; Retrospective Studies; Siblings; Stem Cell Transplantation; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2005 |
Successful engraftment without radiation after fludarabine-based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation.
Topics: Adolescent; Adult; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Child; Child, Preschool; Chronic Disease; Cyclophosphamide; Cyclosporine; Fanconi Anemia; Female; Fetal Blood; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Myelodysplastic Syndromes; Neoplasm Recurrence, Local; Survival Rate; T-Lymphocytes; Treatment Outcome; Vidarabine | 2006 |
[Cyclosporine A based therapy for myelodysplastic syndrome].
Topics: Adolescent; Adult; Aged; Androgens; Anemia, Refractory; Anemia, Refractory, with Excess of Blasts; Calcitriol; Cyclosporine; Drug Therapy, Combination; Erythropoietin; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Myelodysplastic Syndromes; Recombinant Proteins; Treatment Outcome | 2005 |
Update on supportive care and new therapies: immunomodulatory drugs, growth factors and epigenetic-acting agents.
Topics: Angiogenesis Inhibitors; Antilymphocyte Serum; Antineoplastic Agents; Blood Transfusion; Cyclosporine; Granulocyte Colony-Stimulating Factor; Growth Substances; Hemoglobins; Humans; Immunosuppressive Agents; Lenalidomide; Myelodysplastic Syndromes; Quality of Life; Risk Assessment; Thalidomide | 2005 |
[Myelodysplastic syndrome with der (1;7) transformed from aplastic anemia 42 years after onset].
Topics: Anemia, Aplastic; Blood Transfusion; Bone Marrow Examination; Chromosomes, Human, Pair 7; Cyclosporine; Humans; Immunosuppressive Agents; Male; Middle Aged; Monosomy; Myelodysplastic Syndromes; Severity of Illness Index; Time Factors | 2005 |
Cyclosporine-responsive thrombocytopenia in a patient with chloramphenicol-associated myelodysplastic syndrome.
Topics: Chloramphenicol; Cyclosporine; Humans; Immunosuppressive Agents; Middle Aged; Myelodysplastic Syndromes; Pancytopenia; Platelet Count; Thrombocytopenia | 2006 |
Severe regimen-related toxicity of second transplantation for graft failure following reduced-intensity cord blood transplantation in an adult patient.
Topics: Adult; Aged; Bone Marrow Transplantation; Cord Blood Stem Cell Transplantation; Cyclosporine; Graft Rejection; HLA Antigens; Humans; Male; Myelodysplastic Syndromes; Time Factors; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 2006 |
Myelodysplastic syndrome.
Topics: Antilymphocyte Serum; Cyclosporine; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Myelodysplastic Syndromes; Radiotherapy; Stem Cells | 2005 |
Determining which patients with myelodysplastic syndrome will respond to immunosuppressive treatment.
Topics: Adult; Age Factors; Aged; Antilymphocyte Serum; Autoimmune Diseases; Blood Transfusion; Chromosomes, Human, Pair 8; Cyclosporine; Etanercept; HLA-DR Antigens; Humans; Immunoglobulin G; Immunosuppressive Agents; Middle Aged; Multicenter Studies as Topic; Myelodysplastic Syndromes; Pancytopenia; Patient Selection; Predictive Value of Tests; Prognosis; Receptors, Tumor Necrosis Factor; T-Lymphocytes; Treatment Outcome; Trisomy; Tumor Necrosis Factor-alpha | 2006 |
Effect of blood cyclosporine concentration on the outcome of hematopoietic stem cell transplantation from an HLA-matched sibling donor.
Topics: Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Infusions, Intravenous; Kidney; Leukemia; Male; Myelodysplastic Syndromes; Retrospective Studies; Siblings | 2006 |
Immune-mediated myelopathy following allogeneic stem cell transplantation.
Topics: Adult; Anti-Inflammatory Agents; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Methylprednisolone; Myelodysplastic Syndromes; Pancytopenia; Spinal Cord Diseases; Stem Cell Transplantation; Transplantation Chimera; Transplantation, Homologous | 2006 |
Granulocyte-stimulating factor and severe aplastic anemia: a survey by the European Group for Blood and Marrow Transplantation (EBMT).
Topics: Adolescent; Adult; Anemia, Aplastic; Antilymphocyte Serum; Cyclosporine; Data Collection; Europe; Female; Granulocyte Colony-Stimulating Factor; Humans; Immunosuppressive Agents; Male; Middle Aged; Myelodysplastic Syndromes; Recombinant Proteins; Risk Factors | 2007 |
[Curative effects of cyclosporin A therapy upon myelodysplastic syndrome].
Topics: Adolescent; Adult; Aged; Child; Cyclosporine; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Myelodysplastic Syndromes; Prospective Studies; Treatment Outcome | 2006 |
Pseudotumor cerebri after allogeneic bone marrow transplant associated with cyclosporine a use for graft-versus-host disease prophylaxis.
Topics: Adolescent; Bone Marrow Transplantation; Child; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pseudotumor Cerebri; Transplantation, Homologous | 2007 |
[Myelodysplastic syndrome with cyclosporine A-induced encephalopathy presenting with a mass effect on the right basal ganglia after cord blood transplantation].
Topics: Acute Disease; Adolescent; Basal Ganglia; Brain Edema; Cord Blood Stem Cell Transplantation; Cyclosporine; Diffusion Magnetic Resonance Imaging; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Myelodysplastic Syndromes; Neurotoxicity Syndromes; Syndrome | 2006 |
Immunosuppressive therapy with anti-thymocyte globulin and cyclosporine A in selected children with hypoplastic refractory cytopenia.
Topics: Antilymphocyte Serum; Blood Transfusion; Child; Combined Modality Therapy; Cyclosporine; Disease Progression; Disease-Free Survival; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Leukocyte Count; Myelodysplastic Syndromes; Prednisone; Prospective Studies; Recurrence; Remission Induction; Statistics, Nonparametric; T-Lymphocytes; Treatment Outcome | 2007 |
Long-term outcome of patients with acquired primary idiopathic pure red cell aplasia receiving cyclosporine A. A nationwide cohort study in Japan for the PRCA Collaborative Study Group.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Autoimmune Diseases; Cohort Studies; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Drug Evaluation; Female; Follow-Up Studies; Health Surveys; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Japan; Male; Middle Aged; Myelodysplastic Syndromes; Preleukemia; Recurrence; Red-Cell Aplasia, Pure; Remission Induction; Salvage Therapy; Survival Analysis; Treatment Outcome | 2007 |
Transformation of childhood MDS-refractory anemia to acute lymphoblastic leukemia.
Topics: Anemia, Refractory; Child; Cyclosporine; Flow Cytometry; Humans; Immunophenotyping; Immunosuppressive Agents; Male; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2007 |
[Allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia].
Topics: Acute Disease; Adolescent; Adult; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Male; Methotrexate; Middle Aged; Multivariate Analysis; Myelodysplastic Syndromes; Retrospective Studies; Risk Factors; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous | 2007 |
[A case of autoimmune hemolytic anemia complicating hematopoietic cell transplantation].
Topics: Adult; Anemia, Hemolytic, Autoimmune; Combined Modality Therapy; Cyclosporine; Hematopoietic Stem Cell Transplantation; Humans; Male; Mycophenolic Acid; Myelodysplastic Syndromes; Plasma Exchange | 2008 |
Factors affecting response and survival in patients with myelodysplasia treated with immunosuppressive therapy.
Topics: Antilymphocyte Serum; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Male; Middle Aged; Myelodysplastic Syndromes; Palliative Care; Prognosis; Survival; Treatment Outcome | 2008 |
Unrelated bone marrow donor transplants for children with leukemia or myelodysplasia.
Topics: Actuarial Analysis; Adolescent; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Cytarabine; Disease-Free Survival; Female; Graft vs Host Disease; Hepatic Veno-Occlusive Disease; Histocompatibility; Humans; Infections; Leukemia; Lung Diseases, Interstitial; Male; Methylprednisolone; Myelodysplastic Syndromes; Retrospective Studies; Risk Factors; Survival Analysis; Tissue Donors; Treatment Outcome; Whole-Body Irradiation; Wisconsin | 1995 |
Graft failure in children receiving HLA-mismatched marrow transplants with busulfan-containing regimens.
Topics: Adolescent; Adult; Age Factors; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Combined Modality Therapy; Cyclosporine; Cytarabine; Drug Therapy, Combination; Graft Rejection; Histocompatibility; HLA Antigens; Humans; Incidence; Leukemia, Myeloid, Acute; Middle Aged; Myelodysplastic Syndromes; Risk Factors; Tissue Donors | 1994 |
Acute graft-versus-host disease prophylaxis with methotrexate and cyclosporine after busulfan and cyclophosphamide in patients with hematologic malignancies.
Topics: Adult; Busulfan; Chronic Disease; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Incidence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Time Factors | 1993 |
Donor buffy coat infusions for a patient with myelodysplastic syndrome who relapsed following allogeneic bone marrow transplantation.
Topics: Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Humans; Leukocyte Transfusion; Male; Middle Aged; Myelodysplastic Syndromes; Prednisolone; Recurrence | 1995 |
Donor leucocyte transfusions for relapse in myelodyplastic syndrome after allogeneic bone marrow transplantation.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Humans; Leukocyte Transfusion; Male; Myelodysplastic Syndromes; Prednisolone; Recurrence; Transplantation, Autologous | 1996 |
Eosinophilic fasciitis with myelodysplasia responsive to treatment with cyclosporin.
Topics: Aged; Cyclosporine; Eosinophilia; Fasciitis; Female; Humans; Immunosuppressive Agents; Myelodysplastic Syndromes | 1997 |
Immunosuppressive therapy for hypoplastic myelodysplastic syndrome.
Topics: Antilymphocyte Serum; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Myelodysplastic Syndromes; Prednisone | 1997 |
[Reversible leukoencephalopathy related to cyclosporin treatment].
Topics: Adult; Bone Marrow Transplantation; Bone Transplantation; Brain Edema; Cyclosporine; Female; Graft Rejection; Humans; Hypertension; Magnetic Resonance Imaging; Myelodysplastic Syndromes; Transplantation, Autologous | 1997 |
Busulfan/cyclophosphamide in volunteer unrelated donor (VUD) BMT: excellent feasibility and low incidence of treatment-related toxicity.
Topics: Adult; Antilymphocyte Serum; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia; Living Donors; Male; Methotrexate; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; T-Lymphocytes; Transplantation Conditioning | 1997 |
Myelodysplastic syndrome and acute myelogenous leukemia as a late clonal complication in children with acquired aplastic anemia.
Topics: Acute Disease; Adolescent; Anemia, Aplastic; Bone Marrow Transplantation; Child; Child, Preschool; Chromosomes, Human, Pair 7; Clone Cells; Combined Modality Therapy; Cyclosporine; Drug Synergism; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Infant; Leukemia, Myeloid; Life Tables; Male; Monosomy; Myelodysplastic Syndromes; Recombinant Proteins; Retrospective Studies; Risk Factors; Survival Analysis; Survival Rate | 1997 |
[Myelodysplastic syndrome with monosomy 7 following combination therapy with granulocyte colony-stimulating factor, cyclosporin A and danazole in an adult patient with severe aplastic anemia].
Topics: Adult; Anemia, Aplastic; Chromosomes, Human, Pair 7; Cyclosporine; Danazol; Female; Granulocyte Colony-Stimulating Factor; Humans; Immunosuppressive Agents; Monosomy; Myelodysplastic Syndromes | 1997 |
Bullous pyoderma gangrenosum in a patient with myelodysplastic syndrome during granulocyte colony-stimulating factor therapy.
Topics: Aged; Cyclosporine; Granulocyte Colony-Stimulating Factor; Humans; Immunosuppressive Agents; Male; Myelodysplastic Syndromes; Pyoderma Gangrenosum; Skin Diseases, Vesiculobullous | 1997 |
[Hypoplastic myelodysplastic syndrome progressing to acute myelocytic leukemia (M2) after treatment with G-CSF and immunosuppressants].
Topics: Adult; Anemia, Aplastic; Cyclosporine; Diagnosis, Differential; Female; Granulocyte Colony-Stimulating Factor; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Pancytopenia; Pregnancy; Pregnancy Complications, Hematologic; Purpura, Thrombocytopenic, Idiopathic | 1998 |
Long-term administration of G-CSF for aplastic anaemia is closely related to the early evolution of monosomy 7 MDS in adults.
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Chromosomes, Human, Pair 7; Cyclosporine; Drug Administration Schedule; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Immunosuppressive Agents; Male; Middle Aged; Monosomy; Myelodysplastic Syndromes; Retrospective Studies; Risk Factors; Survival Rate | 1998 |
Myelodysplastic syndrome in an infant: induction of remission by cyclosporin.
Topics: Cyclosporine; Humans; Immunosuppressive Agents; Infant; Male; Myelodysplastic Syndromes; Remission Induction | 1998 |
Posterior leukoencephalopathy syndrome may not be reversible.
Topics: Bone Marrow Transplantation; Brain Diseases; Child, Preschool; Chromosomes, Human, Pair 7; Cyclosporine; Disease Progression; Humans; Hypertension, Malignant; Leukemia, Myeloid, Acute; Magnetic Resonance Imaging; Male; Monosomy; Myelodysplastic Syndromes; Occipital Lobe; Ocular Motility Disorders; Syndrome; Tomography, X-Ray Computed | 1999 |
Myelodysplastic syndrome with monosomy 7 after immunosuppressive therapy in Behçet's disease.
Topics: Adult; Antineoplastic Agents, Alkylating; Behcet Syndrome; Bone Marrow Cells; Chlorambucil; Chromosomes, Human, Pair 7; Cyclosporine; Fatal Outcome; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Monosomy; Myelodysplastic Syndromes | 1999 |
Unusual clinical presentation in a patient with myelodysplastic syndrome, with subsequent hematological remission and suppression of the malignant clone following treatment with cyclosporine A, erythropoietin and granulocyte colony-stimulating factor.
Topics: Adult; Autoimmune Diseases; Cyclosporine; Disease Progression; Drug Therapy, Combination; Erythropoietin; Female; Granulocyte Colony-Stimulating Factor; Humans; Myelodysplastic Syndromes; Platelet Count; Remission Induction; Thrombocytopenia | 1999 |
Comparison of P-glycoprotein expression and function with in vitro sensitivity to anthracyclines in AML.
Topics: Acridines; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blast Crisis; Bone Marrow; Cell Survival; Cyclosporine; Daunorubicin; Gene Expression Regulation, Neoplastic; Humans; Isoquinolines; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Recurrence; Tetrahydroisoquinolines; Tumor Cells, Cultured | 1999 |
[Successful immunosuppressive therapy for a patient with hypoplastic myelodysplastic syndrome].
Topics: Adolescent; Antilymphocyte Serum; Bone Marrow; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Karyotyping; Myelodysplastic Syndromes; Treatment Outcome | 1999 |
Long-term improvement of hematopoiesis following cyclosporine treatment in a patient with myelodysplastic syndrome.
Topics: Adult; Anemia, Refractory; Bone Marrow; Cyclosporine; Erythrocyte Transfusion; Follow-Up Studies; Hematopoiesis; Humans; Immunosuppressive Agents; Male; Myelodysplastic Syndromes; Platelet Transfusion; Treatment Outcome | 1999 |
Good response to cyclosporine therapy in patients with myelodysplastic syndromes having the HLA-DRB1*1501 allele.
Topics: Adult; Aged; Alleles; Cyclosporine; Female; Genotype; HLA-DR Antigens; HLA-DRB1 Chains; Humans; Immunosuppressive Agents; Male; Middle Aged; Myelodysplastic Syndromes; Treatment Outcome | 2000 |
Transformation of severe aplastic anemia into myelodysplastic syndrome with monosomy 7: monoclonal origin detected by HUMARA gene analysis during the aplastic anemia phase.
Topics: Aged; Anemia, Aplastic; Chromosomes, Human, Pair 7; Clone Cells; Cyclosporine; Cytogenetic Analysis; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Monosomy; Myelodysplastic Syndromes; Receptors, Androgen | 2000 |
Cyclosporin A-related cerebral vasculopathy.
Topics: Adult; Blood Flow Velocity; Cerebral Angiography; Cerebrovascular Disorders; Crohn Disease; Cyclosporine; Female; Humans; Magnetic Resonance Imaging; Myelodysplastic Syndromes; Ultrasonics | 2000 |
Fatal cerebral hemorrhage associated with cyclosporin-A/FK506-related encephalopathy after allogeneic bone marrow transplantation.
Topics: Adolescent; Bone Marrow Transplantation; Brain Diseases; Cerebral Hemorrhage; Cyclosporine; Female; Humans; Myelodysplastic Syndromes; Tacrolimus | 2000 |
Clinical course and predictive factors for cyclosporin-induced autologous graft-versus-host disease after autologous haematopoietic stem cell transplantation.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Breast Neoplasms; Chi-Square Distribution; Child; Child, Preschool; Cyclosporine; Disease-Free Survival; Female; Graft vs Leukemia Effect; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; HLA-B Antigens; HLA-DR6 Antigen; Hodgkin Disease; Humans; Immunosuppressive Agents; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Myelodysplastic Syndromes; Prospective Studies; Transplantation, Autologous | 2000 |
Combination therapy with tacrolimus and anti-thymocyte globulin for the treatment of steroid-resistant acute graft-versus-host disease developing during cyclosporine prophylaxis.
Topics: Acute Disease; Adult; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Isoantibodies; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma; Male; Methotrexate; Middle Aged; Multiple Myeloma; Myelodysplastic Syndromes; Tacrolimus; Transplantation, Homologous | 2001 |
Anaplastic large-cell lymphoma which showed severe inflammatory status and myelodysplasia with increased VEGF and IL-6 serum levels after long-term immunosuppressive therapy.
Topics: Abdominal Pain; Antineoplastic Combined Chemotherapy Protocols; Autoimmune Diseases; Bleomycin; Bone Marrow; CD4-CD8 Ratio; Cell Lineage; Combined Modality Therapy; Cyclosporine; Dacarbazine; DNA, Neoplasm; DNA, Viral; Doxorubicin; Endothelial Growth Factors; Fever; Fibroblast Growth Factor 2; Gene Rearrangement, B-Lymphocyte; Humans; Immunocompromised Host; Immunosuppressive Agents; Inflammation; Interleukin-6; Lymph Nodes; Lymphokines; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Myelodysplastic Syndromes; Pancytopenia; Prednisolone; Remission Induction; Splenectomy; Syndrome; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Vinblastine | 2001 |
[Successful cyclosporine therapy for a young patient with refractory anemia, myelodysplastic syndrome].
Topics: Adult; Cyclosporine; Female; Humans; Immunosuppressive Agents; Myelodysplastic Syndromes | 2001 |
Successful treatment with cyclosporin A for myelodysplastic syndrome with erythroid hypoplasia associated with T-cell receptor gene rearrangements.
Topics: Aged; Anemia, Aplastic; Blotting, Southern; Cyclosporine; Female; Gene Rearrangement, beta-Chain T-Cell Antigen Receptor; Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor; Gene Rearrangement, T-Lymphocyte; Humans; Immunosuppressive Agents; Male; Middle Aged; Myelodysplastic Syndromes; Polymerase Chain Reaction | 2001 |
Reversible posterior leucoencephalopathy syndrome associated with bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Brain; Brain Diseases; Child; Creatinine; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Headache; Humans; Hypertension; Immunosuppressive Agents; Kidney Failure, Chronic; Male; Middle Aged; Myelodysplastic Syndromes; Nervous System Diseases; Syndrome | 2001 |
Reversible acceleration of disease progression following cyclosporin A treatment in a patient with myelodysplastic syndrome.
Topics: Adult; Anemia, Refractory, with Excess of Blasts; Asian People; Blood Cell Count; Bone Marrow; Cyclosporine; Disease Progression; Female; Humans; Immunosuppressive Agents; Japan; Myelodysplastic Syndromes; Treatment Outcome | 2002 |
[Treatment of myelodysplastic syndromes with immunosuppressive agents].
Topics: Adolescent; Adult; Aged; Cyclosporine; Disease Progression; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Myelodysplastic Syndromes; Retrospective Studies | 2002 |
[Relationship between response to cyclosporine treatment and HLA-DR in MDS].
Topics: Aged; Cyclosporine; HLA-DR Antigens; Humans; Male; Middle Aged; Myelodysplastic Syndromes | 2002 |
Pure red cell aplasia developing into myeloproliferation with myelodysplasia and subsequent leukemia after cyclosporin A therapy.
Topics: Cell Division; Chromosomes, Human, Pair 8; Cyclosporine; Fatal Outcome; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Myeloproliferative Disorders; Red-Cell Aplasia, Pure; Trisomy | 2002 |
Effective prevention of acute GVHD following allogeneic BMT with low leukaemic relapse using methotrexate and therapeutically monitored levels of cyclosporin A.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Leukemia; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Recurrence | 1992 |
Hemolysis of transfused group O red blood cells in minor ABO-incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexate.
Topics: ABO Blood-Group System; Adult; Anemia, Aplastic; Antibodies; Blood Component Transfusion; Blood Group Incompatibility; Bone Marrow Transplantation; Coombs Test; Cyclosporine; Hemolysis; Humans; Immunosuppression Therapy; Leukemia; Methotrexate; Middle Aged; Myelodysplastic Syndromes | 1992 |
An effective acute graft-vs.-host disease prophylaxis with minidose methotrexate, cyclosporine, and single-dose methylprednisolone.
Topics: Bone Marrow Transplantation; Cyclosporine; Dose-Response Relationship, Drug; Graft vs Host Disease; Humans; Leukemia; Methotrexate; Methylprednisolone; Multiple Myeloma; Myelodysplastic Syndromes | 1991 |